Clinical Trial Update: Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating insulin glulisine, insulin lispro, and insulin glargine in adults with Type 1 or Type 2 diabetes; the study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin glulisine (insulin glulisine)
• insulin lispro (insulin lispro)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED